Abstract
Design of biocompatible and biodegradable polymer systems for sustained and controlled release of bioactive agents is critical for numerous biomedical applications. Here, we designed, synthesized, and characterized four polyurethane carrier systems for controlled release of model drugs. These polyurethanes are biocompatible and biodegradable because they consist of biocompatible poly(ethylene glycol) or poly(caprolactone diol) as soft segment, linear aliphatic hexamethylene diisocyanate or symmetrical aliphatic cyclic dicyclohexylmethane-4,4′-diisocyanate as hard segment, and biodegradable urethane linkage. They were characterized with Fourier transform infrared spectroscopy, atomic force microscope, and differential scanning calorimetry, whereas their degradation behaviors were investigated in both phosphate buffered saline and enzymatic solutions. By tuning polyurethane segments, different release profiles of hydrophobic and hydrophilic drugs were obtained in the absence and presence of enzymes. Such difference in release profiles was attributed to a complex interplay among structure, hydrophobicity, and degradability of polyurethanes, the size and hydrophobicity of drugs, and drug-polymer interactions. Different drug-polyurethane combinations modulated the distribution and location of the drugs in polymer matrix, thus inducing different drug release mechanisms. Our results highlight an important role of segmental structure of the polyurethane as an engineering tool to control drug release.
Similar content being viewed by others
References
Hashizume R, Fujimoto K L, Hong Y, Amoroso N J, Tobita K, Miki T, Keller B B, Sacks M S, Wagner W R. Morphological and mechanical characteristics of the reconstructed rat abdominal wall following use of a wet electrospun biodegradable polyurethane elastomer scaffold. Biomaterials, 2010, 31(12): 3253–3265
McDevitt T C, Woodhouse K A, Hauschka S D, Murry C E, Stayton P S. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. Journal of Biomedical Materials Research Part A, 2003, 66A(3): 586–595
Guelcher S A. Biodegradable polyurethanes: Synthesis and applications in regenerative medicine. Tissue Engineering Part B Reviews, 2008, 14(1): 3–17
Sarkar D, Yang J C, Lopina S T. Structure-property relationship of L-tyrosine-based polyurethanes for biomaterial applications. Journal of Applied Polymer Science, 2008, 108(4): 2345–2355
Skarja G A, Woodhouse K A. Structure-property relationships of degradable polyurethane elastomers containing an amino acid-based chain extender. Journal of Applied Polymer Science, 2000, 75(12): 1522–1534
Hong Y, Guan J, Fujimoto K L, Hashizume R, Pelinescu A L, Wagner W R. Tailoring the degradation kinetics of poly(ester carbonate urethane)urea thermoplastic elastomers for tissue engineering scaffolds. Biomaterials, 2010, 31(15): 4249–4258
Wang Z, Yu L, Ding M, Tan H, Li J, Fu Q. Preparation and rapid degradation of nontoxic biodegradable polyurethanes based on poly (lactic acid)-poly(ethylene glycol)-poly(lactic acid) and l-lysine diisocyanate. Polymer Chemistry, 2011, 2(3): 601–607
Sarkar D, Yang J C, Gupta A S, Lopina S T. Synthesis and characterization of L-tyrosine based polyurethanes for biomaterial applications. Journal of Biomedical Materials Research Part A, 2009, 90A(1): 263–271
Skarja G A, Woodhouse K A. Synthesis and characterization of degradable polyurethane elastomers containing an amino acid-based chain extender. Journal of Biomaterials Science, Polymer Edition, 1998, 9(3): 271–295
Sarkar D, Lopina S T. Oxidative and enzymatic degradations of l-tyrosine based polyurethanes. Polymer Degradation and Stability, 2007, 92(11): 1994–2004
Hassan M K, Mauritz K A, Storey R F, Wiggins J S. Biodegradable aliphatic thermoplastic polyurethane based on poly(ɛ-caprolactone) and L-lysine diisocyanate. Journal of Polymer Science Part A: Polymer Chemistry, 2006, 44(9): 2990–3000
Guelcher S A, Srinivasan A, Dumas J E, Didier J E, McBride S, Hollinger J O. Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates. Biomaterials, 2008, 29(12): 1762–1775
van Minnen B, Stegenga B, van Leeuwen M B M, van Kooten T G, Bos R R M. A long-term in vitro biocompatibility study of a biodegradable polyurethane and its degradation products. Journal of Biomedical Materials Research Part A, 2006, 76A(2): 377–385
Park D, Wu W, Wang Y. A functionalizable reverse thermal gel based on a polyurethane/PEG block copolymer. Biomaterials, 2011, 32(3): 777–786
Garrett J T, Siedlecki C A, Runt J. Microdomain morphology of poly(urethane urea) multiblock copolymers. Macromolecules, 2001, 34(20): 7066–7070
Martin D J, Meijs G F, Gunatillake P A, Yozghatlian S P, Renwick G M. The influence of composition ratio on the morphology of biomedical polyurethanes. Journal of Applied Polymer Science, 1999, 71(6): 937–952
Fernández d’Arlas B, Rueda L, de la Caba K, Mondragon I, Eceiza A. Microdomain composition and properties differences of biodegradable polyurethanes based on MDI and HDI. Polymer Engineering & Science, 2008, 48(3): 519–529
Hood M A, Wang B, Sands J M, La Scala J J, Beyer F L, Li C Y. Morphology control of segmented polyurethanes by crystallization of hard and soft segments. Polymer, 2010, 51(10): 2191–2198
James Korley L T, Liff S M, Kumar N, McKinley G H, Hammond P T. Preferential association of segment blocks in polyurethane nanocomposites. Macromolecules, 2006, 39(20): 7030–7036
Petrović Z S, Ferguson J. Polyurethane elastomers. Progress in Polymer Science, 1991, 16(5): 695–836
Waletzko R S, Korley L T J, Pate B D, Thomas E L, Hammond P T. Role of increased crystallinity in deformation-induced structure of segmented thermoplastic polyurethane elastomers with PEO and PEO-PPO-PEO soft segments and HDI hard segments. Macromolecules, 2009, 42(6): 2041–2053
Takahara A, Hergenrother R W, Coury A J, Cooper S L. Effect of soft segment chemistry on the biostability of segmented polyurethanes. II. In vitro hydrolytic degradation and lipod sorption. Journal of Biomedical Materials Research, 1992, 26(6): 801–818
Desai S, Thakore I M, Sarawade B D, Devi S. Effect of polyols and diisocyanates on thermo-mechanical and morphological properties of polyurethanes. European Polymer Journal, 2000, 36(4): 711–725
Uhrich K E, Cannizzaro S M, Langer R S, Shakesheff K M. Polymeric systems for controlled drug release. Chemical Reviews, 1999, 99(11): 3181–3198
Caldorera-Moore M E, Liechty W B, Peppas N A. Responsive theranostic systems: Integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. Accounts of Chemical Research, 2011, 44(10): 1061–1070
Peppas N A, Keys K B, Torres-Lugo M, Lowman A M. Poly (ethylene glycol)-containing hydrogels in drug delivery. Journal of Controlled Release, 1999, 62(1–2): 81–87
Langer R. Polymer-controlled drug delivery systems. Accounts of Chemical Research, 1993, 26(10): 537–542
Edlund U, Albertsson A C. Degradable polymer microspheres for controlled drug delivery. In: Degradable Aliphatic Polyesters. Berlin: Springer Berlin Heidelberg, 2002, 157: 67–112
Kissel T, Li Y, Unger F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Advanced Drug Delivery Reviews, 2002, 54(1): 99–134
Jain R A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21(23): 2475–2490
Shen E, Kipper M J, Dziadul B, Lim M K, Narasimhan B. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. Journal of Controlled Release, 2002, 82(1): 115–125
Puttipipatkhachorn S, Nunthanid J, Yamamoto K, Peck G E. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. Journal of Controlled Release, 2001, 75(1–2): 143–153
Yui N, Kataoka K, Yamada A, Sakurai Y, Sanui K, Ogata N. Drug release from monolithic devices of segmented polyether-poly (urethane-urea)s having both hydrophobic and hydrophilic soft segments. Die Makromolekulare Chemie, Rapid Communications, 1986, 7(11): 747–750
Yui N, Kataoka K, Yamada A, Sakurai Y. Novel design of microreservoir-dispersed matrices for drug delivery formulations: Regulative drug release from poly(ethylene oxide)- and poly (tetramethylene oxide)-based segmented polyurethanes. Journal of Controlled Release, 1987, 6(1): 329–342
Sarkar D, Yang J C, Gupta A S, Lopina S T. Synthesis and characterization of L-tyrosine based polyurethanes for biomaterial applications. Journal of Biomedical Materials Research Part A, 2009, 90A(1): 263–271
Yang J C, Zhao C, Hsieh I F, Subramanian S, Liu L, Cheng G, Li L, Cheng S Z D, Zheng J. Strong resistance of poly (ethylene glycol) based L-tyrosine polyurethanes to protein adsorption and cell adhesion. Polymer International, 2012, 61(4): 616–621
Guo Q, Knight P T, Mather P T. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. Journal of Controlled Release, 2009, 137(3): 224–233
Yamaoka T, Makita Y, Sasatani H, Kim S I, Kimura Y. Linear type azo-containing polyurethane as drug-coating material for colonspecific delivery: Its properties, degradation behavior, and utilization for drug formulation. Journal of Controlled Release, 2000, 66(2-3): 187–197
Hong Y, Ye S H, Pelinescu A L, Wagner W R. Synthesis, characterization, and paclitaxel release from a biodegradable, elastomeric, poly(ester urethane)urea bearing phosphorylcholine groups for reduced thrombogenicity. Biomacromolecules, 2012, 13(11): 3686–3694
Ratner B D, Gladhill K W, Horbett T A. Analysis of in vitro enzymatic and oxidative degradation of polyurethanes. Journal of Biomedical Materials Research, 1988, 22(6): 509–527
Christenson E M, Patel S, Anderson J M, Hiltner A. Enzymatic degradation of poly(ether urethane) and poly(carbonate urethane) by cholesterol esterase. Biomaterials, 2006, 27(21): 3920–3926
Mishra A, Aswal V K, Maiti P. Nanostructure to microstructure selfassembly of aliphatic polyurethanes: The effect on mechanical properties. The Journal of Physical Chemistry B, 2010, 114(16): 5292–5300
Zhou L, Yu L, Ding M, Li J, Tan H, Wang Z, Fu Q. Synthesis and characterization of pH-sensitive biodegradable polyurethane for potential drug delivery applications. Macromolecules, 2011, 44(4): 857–864
Hesketh T R, Van Bogart J W C, Cooper S L. Differential scanning calorimetry analysis of morphological changes in segmented elastomers. Polymer Engineering & Science, 1980, 20(3): 190–197
Siegmann A, Cohen D, Narkis M. Polyurethane elastomers containing polybutadiene and aliphatic diols: Structure-property relationships. Polymer Engineering & Science, 1987, 27(15): 1187–1194
Lee D K, Tsai H B. Properties of segmented polyurethanes derived from different diisocyanates. Journal of Applied Polymer Science, 2000, 75(1): 167–174
Ikeda Y, Kohjiya S, Takesako S, Yamashita S. Polyurethane elastomer with PEO-PTMO-PEO soft segment for sustained release of drugs. Biomaterials, 1990, 11(8): 553–560
Shen E, Pizsczek R, Dziadul B, Narasimhan B. Microphase separation in bioerodible copolymers for drug delivery. Biomaterials, 2001, 22(3): 201–210
Santerre J P, Woodhouse K, Laroche G, Labow R S. Understanding the biodegradation of polyurethanes: From classical implants to tissue engineering materials. Biomaterials, 2005, 26(35): 7457–7470
Huang X, Lowe T L. Biodegradable thermoresponsive hydrogels for aqueous encapsulation and controlled release of hydrophilic model drugs. Biomacromolecules, 2005, 6(4): 2131–2139
Author information
Authors and Affiliations
Corresponding authors
Additional information
These authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Yang, J., Chen, H., Yuan, Y. et al. Synthesis and characterization of biocompatible polyurethanes for controlled release of hydrophobic and hydrophilic drugs. Front. Chem. Sci. Eng. 8, 498–510 (2014). https://doi.org/10.1007/s11705-014-1451-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11705-014-1451-9